Real-time enrollment status for this pik3ca mutations clinical trial
Current Status
Recruiting
Checked: October 10, 2026 at 9:46 PM UTC
| NCT Number | NCT07383506 |
| Recruiting Status | Recruiting |
| Condition | PIK3CA Mutations |
| Phase | PHASE1 |
| Target Enrollment | 90 participants |
| Active Locations | 11 sites in the US |
| Sponsor | Cogent Biosciences, Inc. |
| Last Updated on CT.gov | August 26, 2026 (Aug 26, 2026) |
As of October 10, 2026: Clinical trial NCT07383506 is currently recruiting participants. This phase1 study for pik3ca mutations is actively seeking new participants at 11 locations across the United States. The study is sponsored by Cogent Biosciences, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07383506 is actively recruiting participants as of October 10, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 11 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07383506 was last updated Aug 26, 2026 (August 26, 2026). HelloStudys verifies this status automatically.